Efficacy of Laparoscopic-Assisted TAP Block in Laparoscopic Appendectomy
NCT07921862, Not applicable, Active not recruiting, Erzincan Binali Yildirim University Mengucek Gazi Training and Research Hospital
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Efficacy of Laparoscopic-Assisted TAP Block in Laparoscopic Appendectomy | ClinicalTrials.gov |
| NCT number | NCT07921862 | ClinicalTrials.gov |
| Status | Active not recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 88 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Erzincan Binali Yildirim University Mengucek Gazi Training and Research Hospital | ClinicalTrials.gov |
| Conditions | Appendectomy, Laparoscopic, Blockades Neuromuscular, Analgeisa, Local Analgesia Via Nerve Block | ClinicalTrials.gov |
| Interventions | Bupivacaine (Transversus Abdominis Plane Block) | ClinicalTrials.gov |
| First posted | 2026-11-06 | ClinicalTrials.gov |
| Last updated | 2026-11-06 | ClinicalTrials.gov |
Registered outcomes 6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Postoperative Pain Scores Assessed by the Visual Analog Scale | Postoperative 2nd, 4th, 8th, 12th, and 24th hours | Postoperative pain severity will be evaluated using the Visual Analog Scale. The scale ranges from a minimum value of 0, representing no pain, to a maximum value of 10, representing the worst possible pain. Higher scores mean a worse outcome, indicating more severe pain. | ClinicalTrials.gov |
| Primary | Total Postoperative Analgesic Consumption in Milligrams | First 24 hours postoperatively | The total cumulative dose of intravenous analgesic agents (such as tramadol, paracetamol, or opioids) administered to the patient as rescue analgesia within the first 24 hours after surgery. The total amount will be calculated and recorded in milligrams (mg). Higher cumulative values mean a worse outcome, indicating a greater requirement for pain medication. | ClinicalTrials.gov |
| Secondary | Total Tramadol Consumption | First 24 hours postoperatively | The total cumulative administration of intravenous or oral tramadol provided to the patient as analgesia within the specified postoperative timeframe. The consumption data is documented to assess pain management requirements following the surgical procedure. | ClinicalTrials.gov |
| Secondary | Incidence of Postoperative Nausea and Vomiting | Up to 24 hours postoperatively | The occurrence of postoperative nausea and vomiting (PONV) episodes will be monitored and documented during the first 24 hours after the surgical procedure. This outcome will be recorded as a percentage of patients experiencing symptoms within each study group. Higher percentages mean a worse outcome, indicating a higher rate of postoperative complications. | ClinicalTrials.gov |
| Secondary | Time to First Flatus or Defecation in Hours | Up to hospital discharge (approximately 48 hours) | The time elapsed from the end of the surgery until the first postoperative passage of flatus or defecation, measured in hours. This parameter is used to objectively evaluate gastrointestinal motility recovery. A shorter time frame indicates a better outcome, representing earlier return of bowel function. | ClinicalTrials.gov |
| Secondary | Postoperative Sleep Quality | Postoperative 24 hours. | Assessment of the patient's subjective sleep quality during the first postoperative night (e.g., using a numerical rating scale or questionnaire). | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)